Eddie Hickman
Stock Analyst at Guggenheim
(0)
# 4993
Out of 5,327 analysts
17
Total ratings
0.00%
Success rate
-33.35%
Average return
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
PMN ProMIS Neurosciences | Reiterates: Buy | 6 6 | 0.57 | 952.63% | 2 | Apr 1, 2025 | |
ZVRA Zevra Therapeutics | Maintains: Strong Buy | 20 22 | 7.18 | 206.41% | 1 | Mar 13, 2025 | |
GHRS GH Research | Initiates Coverage On: Buy | 32 | 9.59 | 233.68% | 1 | Mar 13, 2025 | |
CYBN Cybin | Initiates Coverage On: Buy | 35 | 6.93 | 405.05% | 1 | Mar 13, 2025 | |
TARS Tarsus Pharmaceutica... | Maintains: Strong Buy | 75 78 | n/a | n/a | 7 | Feb 26, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 12 12 | 1.52 | 689.47% | 3 | Jan 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | May 1, 2023 |